1 Wang W, Lo ACY. Diabetic Retinopathy: Pathophysiology and Treatments. Int J Mol Sci 2018; 19. doi:10.3390/ijms19061816.
2 Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2017; 2. doi:10.1172/jci.insight.93751.
3 Zong H, Ward M, Madden A, Yong PH, Limb GA, Curtis TM et al. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 2010; 53: 2656–2666.
4 Coughlin L, Morrison RS, Horner PJ, Inman DM. Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve. Invest Ophthalmol Vis Sci 2015; 56: 1437–1446.
5 Mizutani M, Gerhardinger C, Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes 1998; 47: 445–449.
6 Lupien CB, Bolduc C, Landreville S, Salesse C. Comparison between the gene expression profile of human Müller cells and two spontaneous Müller cell lines. Invest Ophthalmol Vis Sci 2007; 48: 5229–5242.
7 Picconi F, Parravano M, Sciarretta F, Fulci C, Nali M, Frontoni S et al. Activation of retinal Müller cells in response to glucose variability. Endocrine 2019; 65: 542–549.
8 Chang M-L, Chiu C-J, Shang F, Taylor A. High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia. Adv Exp Med Biol 2014; 801: 609–621.
9 Li J, Zhao S, Wang P, Yu S, Zheng Z, Xu X. Calcium mediates high glucose-induced HIF-1α and VEGF expression in cultured rat retinal Müller cells through CaMKII-CREB pathway. Acta Pharmacol Sin 2012; 33: 1030–1036.
10 Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M et al. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells. Diabetologia 2011; 54: 1554–1566.
11 Mathes E, O’Dea EL, Hoffmann A, Ghosh G. NF-κB dictates the degradation pathway of IκBα. EMBO J 2008; 27: 1357–1367.
12 Ferreiro DU, Komives EA. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry 2010; 49: 1560–1567.
13 Christian F, Smith EL, Carmody RJ. The Regulation of NF-κB Subunits by Phosphorylation. Cells 2016; 5. doi:10.3390/cells5010012.
14 Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 2018; 18: 309–324.
15 Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Sig Transduct Target Ther 2017; 2: 17023.
16 Sun S-C. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol 2017; 17: 545–558.
17 Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373–428.
18 Livneh I, Cohen-Kaplan V, Cohen-Rosenzweig C, Avni N, Ciechanover A. The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death. Cell Res 2016; 26: 869–885.
19 Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G et al. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges. Pharmacol Ther 2020; 213: 107579.
20 Collins GA, Goldberg AL. The Logic of the 26S Proteasome. Cell 2017; 169: 792–806.
21 Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001; 83: 301–310.
22 Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, Martin A. Complete subunit architecture of the proteasome regulatory particle. Nature 2012; 482: 186–191.
23 Martin A, Baker TA, Sauer RT. Pore loops of the AAA+ ClpX machine grip substrates to drive translocation and unfolding. Nat Struct Mol Biol 2008; 15: 1147–1151.
24 Bard JAM, Goodall EA, Greene ER, Jonsson E, Dong KC, Martin A. Structure and Function of the 26S Proteasome. Annu Rev Biochem 2018; 87: 697–724.
25 Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC et al. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 2011; 13: 129–135.
26 Groettrup M, Kirk CJ, Basler M. Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol 2010; 10: 73–78.
27 Raule M, Cerruti F, Cascio P. Enhanced rate of degradation of basic proteins by 26S immunoproteasomes. Biochim Biophys Acta 2014; 1843: 1942–1947.
28 Cascio P, Call M, Petre BM, Walz T, Goldberg AL. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J 2002; 21: 2636–2645.
29 Cascio P. PA28αβ: the enigmatic magic ring of the proteasome? Biomolecules 2014; 4: 566–584.
30 VerPlank JJS, Goldberg AL. Regulating protein breakdown through proteasome phosphorylation. Biochem J 2017; 474: 3355–3371.
31 VerPlank JJS, Goldberg AL. Exploring the regulation of proteasome function by subunit phosphorylation. Methods Mol Biol 2018; 1844: 309–319.
32 Urru SAM, Veglianese P, De Luigi A, Fumagalli E, Erba E, Gonella Diaza R et al. A new fluorogenic peptide determines proteasome activity in single cells. J Med Chem 2010; 53: 7452–7460.
33 VerPlank JJS, Lokireddy S, Zhao J, Goldberg AL. 26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation. PNAS 2019; 116: 4228–4237.
34 Djakovic SN, Schwarz LA, Barylko B, DeMartino GN, Patrick GN. Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II. J Biol Chem 2009; 284: 26655–26665.
35 Djakovic SN, Marquez-Lona EM, Jakawich SK, Wright R, Chu C, Sutton MA et al. Phosphorylation of Rpt6 regulates synaptic strength in hippocampal neurons. J Neurosci 2012; 32: 5126–5131.
36 Jarome TJ, Kwapis JL, Ruenzel WL, Helmstetter FJ. CaMKII, but not protein kinase A, regulates Rpt6 phosphorylation and proteasome activity during the formation of long-term memories. Front Behav Neurosci 2013; 7. doi:10.3389/fnbeh.2013.00115.
37 Lokireddy S, Kukushkin NV, Goldberg AL. cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci U S A 2015; 112: E7176–E7185.
38 Sbardella D, Tundo GR, Coletta A, Marcoux J, Koufogeorgou EI, Ciaccio C et al. The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S. Cell Mol Life Sci 2018; 75: 3441–3456.
39 Sbardella D, Tundo GR, Sciandra F, Bozzi M, Gioia M, Ciaccio C et al. Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution. PLoS ONE 2015; 10: e0132455.
40 Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia 2018; 61: 1902–1912.
41 Metea MR, Newman EA. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci 2006; 26: 2862–2870.
42 Newman EA. Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters. Philos Trans R Soc Lond B Biol Sci 2015; 370. doi:10.1098/rstb.2014.0195.
43 Shi H, Berger EA. Characterization of Site-Specific Phosphorylation of NF-κB p65 in Retinal Cells in Response to High Glucose and Cytokine Polarization. Mediators Inflamm 2018; 2018. doi:10.1155/2018/3020675.
44 Le Y-Z. VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 2017; 139: 108–114.
45 Li W, Liu X, Tu Y, Ding D, Yi Q, Sun X et al. Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis. Neuropeptides 2020; 82: 102057.
46 Matteucci A, Gaddini L, Villa M, Varano M, Parravano M, Monteleone V et al. Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation. Exp Eye Res 2014; 125: 20–29.
47 Trueblood KE, Mohr S, Dubyak GR. Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1. Am J Physiol Cell Physiol 2011; 301: C1213-1223.
48 Asano S, Fukuda Y, Beck F, Aufderheide A, Förster F, Danev R et al. Proteasomes. A molecular census of 26S proteasomes in intact neurons. Science 2015; 347: 439–442.
49 Bianchi G, Oliva L, Cascio P, Pengo N, Fontana F, Cerruti F et al. The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition. Blood 2009; 113: 3040–3049.
50 Alverdi V, Hetrick B, Joseph S, Komives EA. Direct observation of a transient ternary complex during IκBα-mediated dissociation of NF-κB from DNA. Proc Natl Acad Sci U S A 2014; 111: 225–230.
51 Çetin G, Klafack S, Studencka-Turski M, Krüger E, Ebstein F. The Ubiquitin-Proteasome System in Immune Cells. Biomolecules 2021; 11: 60.
52 Maldonado M, Kapphahn RJ, Terluk MR, Heuss ND, Yuan C, Gregerson DS et al. Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling. PLoS One 2013; 8: e56187.
53 Marquez-Lona EM, Torres-Machorro AL, Gonzales FR, Pillus L, Patrick GN. Phosphorylation of the 19S regulatory particle ATPase subunit, Rpt6, modifies susceptibility to proteotoxic stress and protein aggregation. PLoS One 2017; 12: e0179893.
54 Ben-Nissan G, Sharon M. Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway. Biomolecules 2014; 4: 862–884.
55 Scudder SL, Gonzales FR, Howell KK, Stein IS, Dozier LE, Anagnostaras SG et al. Altered Phosphorylation of the Proteasome Subunit Rpt6 Has Minimal Impact on Synaptic Plasticity and Learning. eNeuro 2021; 8: ENEURO.0073-20.2021.
56 Cenci S, Oliva L, Cerruti F, Milan E, Bianchi G, Raule M et al. Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors. J Leukoc Biol 2012; 92: 921–931.
57 Sarthy VP, Brodjian SJ, Dutt K, Kennedy BN, French RP, Crabb JW. Establishment and characterization of a retinal Müller cell line. Invest Ophthalmol Vis Sci 1998; 39: 212–216.
58 Elsasser S, Schmidt M, Finley D. Characterization of the proteasome using native gel electrophoresis. Meth Enzymol 2005; 398: 353–363.
59 Sbardella D, Coletta A, Tundo GR, Ahmed IMM, Bellia F, Oddone F et al. Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: Novel insights into its pro-proteostatic effect. Biochem Pharmacol 2020; 177: 113977.